We are live on ! Find out more
NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of NKGN yet.

NKGN Hedge Fund Activity: Q1 2026 in Review

1 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Common Stock (NKGN) for Q1 2026, worth a combined $193K — up 40% from $138K a quarter earlier.

Fund positioning in NKGN was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held NKGen Biotech, Inc. Common Stock (NKGN) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $193K of NKGen Biotech, Inc. Common Stock stock for Q1 2026, up 40% quarter-over-quarter.
  • 0 funds opened new NKGen Biotech, Inc. Common Stock positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.